从连亏十年到连获3轮亿元级融资，苏州又冲出一个“独角兽”

Core Insights - Koser Medical has successfully completed nearly 100 million yuan in B+ round financing, led by well-known domestic investment institutions, despite a downturn in the biopharmaceutical and medical device industries [1][2] - The company has achieved profitability for the first time in 2024 after ten years of continuous losses since its establishment in 2013 [3] Financing and Investment - Koser Medical has secured three rounds of financing in the past three years, with the latest round exceeding 100 million yuan [1][2] - The domestic medical device industry saw approximately 300 financing events in 2024, totaling over 20 billion yuan, a 22% decrease from 2023 and a 70% decrease compared to 2021 [2] Product Development and Innovation - The company specializes in vascular interventional devices and has developed two first-in-class products, including a long-acting umbrella-shaped inferior vena cava filter and an electrode guiding sheath set [4] - Koser Medical has hundreds of domestic and international invention patents and over 40 class III medical device registration certificates [4] Support and Growth - The growth of Koser Medical is supported by local government initiatives and investments, particularly from Suzhou state-owned capital [5][6] - The Jiangsu Medical Device Technology Industrial Park, where Koser Medical is located, is a key area supported by the provincial strategy for medical device industry development [8] Future Prospects - The funds from the latest financing round will be used for core product development, global market promotion, and capacity expansion [9] - Investors recognize Koser Medical's platform layout, international strategy, and strong market capabilities, indicating confidence in the company's future potential [11][12]